Trials / Unknown
UnknownNCT01432002
FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer
Application of 18F-[FDG] PET/CT to Simulation and Planning of Radiotherapy (RT) for Breast Cancer. Definition of Target Volume for 3-D RT and for Partial Breast Irradiation (PBI) by IMRT Technique
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- University Hospital, Geneva · Academic / Other
- Sex
- Female
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is: * to assess the potential benefits of 18F-\[FDG\] PET/CT and PET/MRI for operable breast cancer in order to define the size and location of the primary tumor, as well as axillary, supraclavicular and internal mammary lymph nodes. * to apply the imaging results to the simulation and the radiation treatment planning and partial breast for 3-D radiation treatment and partial breast irradiation with intensity modulated radiation treatment (IMRT).
Detailed description
Pre-operative FDG PET/CT, and in option PET/IRM, are intended for women with histologically confirmed operable clinically node-negative breast cancer, in whom breast conserving and post-operative radiotherapy are planned.
Conditions
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2013-05-01
- Completion
- 2023-12-01
- First posted
- 2011-09-12
- Last updated
- 2022-12-21
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01432002. Inclusion in this directory is not an endorsement.